Operating Lease, Liability, Current in USD of VYNE Therapeutics Inc. from Q2 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
VYNE Therapeutics Inc. quarterly Operating Lease, Liability, Current history and change rate from Q2 2019 to Q2 2025.
  • VYNE Therapeutics Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2025 was $25K, a 79.2% decline year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $25K -$95K -79.2% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $63K -$54K -46.2% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $99K -$16K -13.9% Dec 31, 2024 10-Q 2025-08-14
Q3 2024 $123K Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $120K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $117K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $115K +$115K Dec 31, 2023 10-K 2025-03-06
Q4 2022 $0 -$349K -100% Dec 31, 2022 10-K 2024-03-01
Q3 2022 $0 -$277K -100% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $31K -$403K -92.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $117K -$530K -81.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $349K -$408K -53.9% Dec 31, 2021 10-K 2023-03-14
Q3 2021 $277K -$821K -74.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $434K -$811K -65.1% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $647K -$362K -35.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $757K -$335K -30.7% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.1M +$357K +48.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.25M +$530K +74.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.01M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.09M Dec 31, 2019 10-K 2021-03-04
Q3 2019 $741K Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $715K Jun 30, 2019 10-Q 2019-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.